Sir Keir Starmer’s decision to invite Sir Pascal Soriot, AstraZeneca’s chief executive, to Beijing at the beginning of the ...

AstraZeneca will buy a Chinese biopharmaceutical company for up to $1.2 billion to expand its cell therapies pipelines, the Anglo-Swedish pharmaceutical company announced on Tuesday. It has entered ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

AstraZeneca will acquire Chinese cell therapy maker Gracell for up to $1.2 billion, representing an 86% premium to the company’s pre-announcement share price. The U.S. FDA announced an investigation ...

Pharma giant AstraZeneca is pledging $15bn to fund an R&D and manufacturing capacity expansion in China – marking a significant investment into a country touted as an up-and-coming pharma powerhouse.

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

Law360 (June 13, 2025, 3:00 PM EDT)--AstraZeneca said Friday it has entered into a strategic artificial intelligence-driven research partnership with China's CSPC Pharmaceutical Group in a deal worth ...

LONDON, Dec 13 (Reuters Breakingviews) - Pascal Soriot is stuck in a Chinese limbo. In recent months, the CEO of $205 billion drug giant AstraZeneca (AZN.L), opens new tab has seen his China boss ...

(RTTNews) - Chinese police have detained five current and former employees of pharmaceutical giant AstraZeneca (AZN) for questioning regarding potential illegal activities, according to Bloomberg News ...

Find insight on AstraZeneca, Chinese manufacturers and more in the latest Market Talks covering Health Care.